11545 related articles for article (PubMed ID: 12198771)
1. Involvement of tumor cell integrin alpha v beta 3 in hematogenous metastasis of human melanoma cells.
Felding-Habermann B; Fransvea E; O'Toole TE; Manzuk L; Faha B; Hensler M
Clin Exp Metastasis; 2002; 19(5):427-36. PubMed ID: 12198771
[TBL] [Abstract][Full Text] [Related]
2. Expression of integrin alpha(v)beta(3) correlates with activation of membrane-type matrix metalloproteinase-1 (MT1-MMP) and matrix metalloproteinase-2 (MMP-2) in human melanoma cells in vitro and in vivo.
Hofmann UB; Westphal JR; Van Kraats AA; Ruiter DJ; Van Muijen GN
Int J Cancer; 2000 Jul; 87(1):12-9. PubMed ID: 10861447
[TBL] [Abstract][Full Text] [Related]
3. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
[TBL] [Abstract][Full Text] [Related]
4. Activated leukocyte cell adhesion molecule (ALCAM/CD166/MEMD), a novel actor in invasive growth, controls matrix metalloproteinase activity.
Lunter PC; van Kilsdonk JW; van Beek H; Cornelissen IM; Bergers M; Willems PH; van Muijen GN; Swart GW
Cancer Res; 2005 Oct; 65(19):8801-8. PubMed ID: 16204050
[TBL] [Abstract][Full Text] [Related]
5. Coexpression of integrin alpha(v)beta3 and matrix metalloproteinase-2 (MMP-2) coincides with MMP-2 activation: correlation with melanoma progression.
Hofmann UB; Westphal JR; Waas ET; Becker JC; Ruiter DJ; van Muijen GN
J Invest Dermatol; 2000 Oct; 115(4):625-32. PubMed ID: 10998134
[TBL] [Abstract][Full Text] [Related]
6. Molecular role(s) for integrins in human melanoma invasion.
Seftor RE; Seftor EA; Hendrix MJ
Cancer Metastasis Rev; 1999; 18(3):359-75. PubMed ID: 10721490
[TBL] [Abstract][Full Text] [Related]
7. Alpha(v)beta(3) integrin engagement enhances cell invasiveness in human multiple myeloma.
Ria R; Vacca A; Ribatti D; Di Raimondo F; Merchionne F; Dammacco F
Haematologica; 2002 Aug; 87(8):836-45. PubMed ID: 12161360
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of alpha IIb beta 3 integrin in subpopulations of murine melanoma cells with high lung-colonizing ability.
Chang YS; Chen YQ; Timar J; Nelson KK; Grossi IM; Fitzgerald LA; Diglio CA; Honn KV
Int J Cancer; 1992 May; 51(3):445-51. PubMed ID: 1375589
[TBL] [Abstract][Full Text] [Related]
9. An anti-alpha v-integrin antibody that blocks integrin function inhibits the development of a human melanoma in nude mice.
Mitjans F; Sander D; Adán J; Sutter A; Martinez JM; Jäggle CS; Moyano JM; Kreysch HG; Piulats J; Goodman SL
J Cell Sci; 1995 Aug; 108 ( Pt 8)():2825-38. PubMed ID: 7593323
[TBL] [Abstract][Full Text] [Related]
10. Role of platelets, thrombin, integrin IIb-IIIa, fibronectin and von Willebrand factor on tumor adhesion in vitro and metastasis in vivo.
Nierodzik ML; Klepfish A; Karpatkin S
Thromb Haemost; 1995 Jul; 74(1):282-90. PubMed ID: 8578473
[TBL] [Abstract][Full Text] [Related]
11. Osteopontin stimulates tumor growth and activation of promatrix metalloproteinase-2 through nuclear factor-kappa B-mediated induction of membrane type 1 matrix metalloproteinase in murine melanoma cells.
Philip S; Bulbule A; Kundu GC
J Biol Chem; 2001 Nov; 276(48):44926-35. PubMed ID: 11564733
[TBL] [Abstract][Full Text] [Related]
12. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3.
Brooks PC; Strömblad S; Sanders LC; von Schalscha TL; Aimes RT; Stetler-Stevenson WG; Quigley JP; Cheresh DA
Cell; 1996 May; 85(5):683-93. PubMed ID: 8646777
[TBL] [Abstract][Full Text] [Related]
13. alpha(v)beta(3) integrin engagement modulates cell adhesion, proliferation, and protease secretion in human lymphoid tumor cells.
Vacca A; Ria R; Presta M; Ribatti D; Iurlaro M; Merchionne F; Tanghetti E; Dammacco F
Exp Hematol; 2001 Aug; 29(8):993-1003. PubMed ID: 11495705
[TBL] [Abstract][Full Text] [Related]
14. The pattern of metastasis of human melanoma to the central nervous system is not influenced by integrin alpha(v)beta(3) expression.
Küsters B; Westphal JR; Smits D; Ruiter DJ; Wesseling P; Keilholz U; de Waal RM
Int J Cancer; 2001 Apr; 92(2):176-80. PubMed ID: 11291042
[TBL] [Abstract][Full Text] [Related]
15. Intact vitronectin induces matrix metalloproteinase-2 and tissue inhibitor of metalloproteinases-2 expression and enhanced cellular invasion by melanoma cells.
Bafetti LM; Young TN; Itoh Y; Stack MS
J Biol Chem; 1998 Jan; 273(1):143-9. PubMed ID: 9417058
[TBL] [Abstract][Full Text] [Related]
16. Functional activation of integrin alpha V beta 3 in tumor cells expressing membrane-type 1 matrix metalloproteinase.
Deryugina EI; Bourdon MA; Jungwirth K; Smith JW; Strongin AY
Int J Cancer; 2000 Apr; 86(1):15-23. PubMed ID: 10728589
[TBL] [Abstract][Full Text] [Related]
17. Platelets mediate tumor cell adhesion to the subendothelium under flow conditions: involvement of platelet GPIIb-IIIa and tumor cell alpha(v) integrins.
Dardik R; Kaufmann Y; Savion N; Rosenberg N; Shenkman B; Varon D
Int J Cancer; 1997 Jan; 70(2):201-7. PubMed ID: 9009161
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression.
Hofmann UB; Westphal JR; Waas ET; Zendman AJ; Cornelissen IM; Ruiter DJ; van Muijen GN
Br J Cancer; 1999 Nov; 81(5):774-82. PubMed ID: 10555745
[TBL] [Abstract][Full Text] [Related]
19. Fibronectin upregulates gelatinase B (MMP-9) and induces coordinated expression of gelatinase A (MMP-2) and its activator MT1-MMP (MMP-14) by human T lymphocyte cell lines. A process repressed through RAS/MAP kinase signaling pathways.
Esparza J; Vilardell C; Calvo J; Juan M; Vives J; Urbano-Márquez A; Yagüe J; Cid MC
Blood; 1999 Oct; 94(8):2754-66. PubMed ID: 10515879
[TBL] [Abstract][Full Text] [Related]
20. Modified heparins inhibit integrin alpha(IIb)beta(3) mediated adhesion of melanoma cells to platelets in vitro and in vivo.
Zhang C; Liu Y; Gao Y; Shen J; Zheng S; Wei M; Zeng X
Int J Cancer; 2009 Nov; 125(9):2058-65. PubMed ID: 19598263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
